Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01106911 · ClinicalTrials.gov registry record · NA
Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 1,080
- Enrollment target
NCT01106911: Completed NA study, sponsored by University of Pittsburgh.
NCT01106911 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 1,080 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01106911, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,080 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate that digital breast tomosynthesis (DBT) in combination with full field digital mammography (FFDM) has the potential to reduce significantly baseline screening recall rates without a loss in the detection of cancers. The primary hypothesis of the study is that DBT in combination with FFDM will reduce baseline screening mammography recall rates in negative examinations by at least 20%.
Primary Outcome
Recall rates of digital breast tomosynthesis and full field digital mammography in younger women undergoing their initial screening mammogram will be assessed and compared.
Interventions
- DEVICE tomosynthesis and screening mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,080 participants |
| Start Date | 2010-05 |
| Phase | NA |
What the finished NCT01106911 record still lists
NCT01106911 is an interventional study that assigns participants to a tested intervention. Its 1,080 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 1 intervention - of which tomosynthesis and screening mammography is the first listed.
NCT01106911 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01106911 about?
NCT01106911 is a clinical study titled "Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment". The objective of this study is to demonstrate that digital breast tomosynthesis (DBT) in combination with full field digital mammography (FFDM) has the potential to reduce significantly baseline screening recall rates without a loss in the detection of cancers. The primary hypothesis of the study is...
What is the current status of trial NCT01106911?
This trial is currently completed. It is a NA study. The enrollment target is 1,080 participants. The study started on 2010-05.
What interventions are being tested in trial NCT01106911?
The interventions under investigation include: tomosynthesis and screening mammography (DEVICE).
Who is sponsoring clinical trial NCT01106911?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01106911's enrollment target sits among peer trials
1,080 95th of 2000 higher than 1,906 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06074068 · 1,080 participants · NA
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
- NCT07213804 · 1,080 participants · Phase 3
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia